Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Curr Opin Hematol. 2016 Jul;23(4):416–425. doi: 10.1097/MOH.0000000000000256

Figure 2. Summary of kinase alterations documented in histiocytic neoplasms.

Figure 2

Somatic mutations described in (A) BRAF and ARAF, (B) MAP2K1 and MAP3K1, (C) H/N/KRAS, and (D) PIK3CA and PIK3CD, as well as fusions in (E) BRAF, (F) ALK, (G) NTRK1 and (H) ETV3-NCOA2.